← FDA Drug Approvals (Drugs@FDA)
LANTHANUM CARBONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2022-01-24
Drug application
- FDA Application #
ANDA206868- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LANTHANUM CARBONATE
- Generic name
- LANTHANUM CARBONATE
- Active ingredients
- LANTHANUM CARBONATE
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- INVAGEN PHARMS
- Manufacturer
- Cipla USA Inc.
- First approval
- 2022-01-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown